Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory ScienceYasser Fouad, Puneet S. Arora, Henrik Landgren et al.|Figshare|2022Cited by 14
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug‐Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI InitiativeMelissa Palmer, Ajit Dash|Drug Safety|2025Cited by 2